Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRBN | Q96SW2 | 19/20 | 0.56 |
| ▸ | DDB1 | Q16531 | 15/20 | 0.56 |
| ▸ | GSPT1 | P15170 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.46 |
| ▸ | IKZF3 | Q9UKT9 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20442576 | 0.88 | CRBN (0.52) | CRBNDDB1GSPT1ALDH1A1CHRM2 | |
| SCHEMBL23158378 | 0.87 | CRBN (0.50) | CRBNDDB1GSPT1ALDH1A1CHRM2 | |
| SCHEMBL23171823 | 0.87 | CRBN (0.50) | CRBNDDB1GSPT1ALDH1A1CHRM2 | |
| SCHEMBL22318094 | 0.87 | CRBN (0.55) | CRBNDDB1 | |
| SCHEMBL23302014 | 0.87 | CRBN (0.56) | CRBNDDB1GSPT1ALDH1A1CHRM2 | |
| SCHEMBL20231483 | 0.86 | CRBN (0.53) | CRBNDDB1GSPT1IKZF3 | |
| SCHEMBL30906228 | 0.86 | CRBN (0.53) | CRBNDDB1GSPT1IKZF3 | |
| SCHEMBL20234428 | 0.85 | DDB1 (0.72) | CRBNDDB1GSPT1 | |
| SCHEMBL20231478 | 0.85 | CRBN (0.55) | CRBNDDB1ALDH1A1CHRM2OPRM1 | |
| SCHEMBL27098401 | 0.85 | GPR119 (0.54) | CRBNDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3835298-B1 | NOVEL CHROMAN DERIVATIVES HAVING ESTROGEN RECEPTOR DEGRADATION ACTIVITY AND USES THEREOF | ACCUTAR BIOTECHNOLOGY INC (US) | 2024-06-26 | — | — | EP | disclosed |